Oral vitamin D to help prevent liver cancer in hepatitis B
Treatments studied
Part of Cancer, Digestive system, Infections clinical trials.
This trial tests whether taking vitamin D by mouth can lower the risk of developing liver cancer (hepatocellular carcinoma) in adults with long-term hepatitis B. It may help by supporting liver health over time, especially for people already on hepatitis B antiviral treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 to 70 and have chronic hepatitis B
- Your hepatitis B blood tests fit the study pattern and you are on anti-viral medicine
- Your scan shows no liver cancer at the start of the study
- Your liver function score (MELD) is under 22
- You cannot be pregnant or breastfeeding, and you must use effective birth control during the study
- You can’t have certain other liver/immune conditions or recent major meds that may interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This study looks at how well different hepatitis B treatments help lower the risk of liver cancer. It's for people with chronic hepatitis B who are already using or starting certain antiviral or interferon therapies.
This study tests an added hepatitis B immune medicine (HBV immunoglobulin) in people with chronic hepatitis B who have liver cancer and are planning surgery or a liver transplant. The goal is to see if giving this protection around the time of treatment can help prevent liver cancer from coming back or worsening.
This study looks at how vitamin D levels—and taking high-dose supplements—affect health differences around the time of liver surgery for liver cancer. It aims to see whether improving vitamin D status can improve outcomes during recovery.
This study tracks chronic hepatitis B patients who have a family history of liver cancer to understand their risk. It tests how well current antiviral treatments work in this group.
Hear when a new Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.